KENNETH J WIDDER

CIK 1065168 · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$696.8K

Companies

4

Total Filings

52

Lifetime Open-Market Net

$1.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QDEL Director 45,073 $14.13 $636.9K -$112.0K 31 2026-06-09
PSNL Director 6,250 $9.59 $59.9K $0 4 2026-05-14
Evoke Pharma Inc (EVOK) Delisted Director $11.00 $0 9 2025-12-17
Evoke Pharma Inc (OMED) Delisted Director 1,472,867 $1.30M 7 2018-04-27

Recent Filings · Page 5 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-05-18 QDEL Mixed +2,984 $0 EDGAR
2017-05-09 QDEL Exer (M) +2,107 $0 EDGAR
2017-05-05 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
2017-02-24 Evoke Pharma Inc (OMED) Delisted Buy (P) +450,000 $1.30M EDGAR
2016-05-19 QDEL Grant (A) $0 EDGAR
2016-05-09 QDEL Exer (M) +962 $0 EDGAR
2016-04-29 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
2015-05-06 QDEL Mixed +157 $0 EDGAR
2015-04-24 Evoke Pharma Inc (OMED) Delisted Grant (A) $0 EDGAR
2014-11-19 QDEL Grant (A) $0 EDGAR
Showing 4150 of 52
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.